We read with great interest the paper by Chou et al. [
], in which they concluded that high premature ventricular complex (PVC) burden was not associated with poor composite adverse maternal and neonatal outcomes. This is an interesting study because it indicates that anti-arrhythmic drugs are not required for pregnant women with PVC, which may reduce the risk of fetal exposure to adverse drug reactions. However, we have some serious concerns about this paper.
- Chou C.C.
- Lee H.L.
- Wo H.T.
- Chang P.C.
- Chiang C.Y.
- Chiu K.P.
- et al.
Obstetric and fetal/neonatal outcomes in pregnant women with frequent premature ventricular complexes and structurally normal heart.
Int. J. Cardiol. 2023; 371: 160-166
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to International Journal of Cardiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Obstetric and fetal/neonatal outcomes in pregnant women with frequent premature ventricular complexes and structurally normal heart.Int. J. Cardiol. 2023; 371: 160-166
- The burden of premature ventricular contractions predicts adverse fetal and neonatal outcomes among pregnant women without structural heart disease: a prospective cohort study.Clin. Cardiol. 2021; 44: 833-838
- Impact of frequent premature ventricular contractions on pregnancy outcomes.Heart. 2018; 104: 1370-1375
Published online: May 26, 2023
Accepted: May 23, 2023
Received: May 2, 2023
Publication stageIn Press Journal Pre-Proof
© 2023 Elsevier B.V. All rights reserved.